Healthcare And Pharmaceutical Category Archives - Page 6 Of 104

Public Health, Disease Prevention & Wellness

EU Approves Amgen’s UPLIZNA for Generalized Myasthenia

PR NewswireFebruary 13, 2026February 13, 2026

by PR NewswireFebruary 13, 2026February 13, 2026025

First and Only CD19-Targeted Therapy Approved in Europe for Adults with anti-AChR+ and anti-MuSK+ gMG UPLIZNA Demonstrates Durable Disease Control with Twice-Yearly Dosing* Amgen (NASDAQ:AMGN)...

Clinical Research, Pharma & Healthcare Financing

HanchorBio Gets FDA Orphan Drug Status for HCB101

PR NewswireFebruary 13, 2026February 13, 2026

by PR NewswireFebruary 13, 2026February 13, 2026033

First SIRPα-IgG4 Fc Fusion Protein Granted Orphan Status in Gastric Cancer HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology...

Digital Health, Technology & Innovation

EYE PCR Gets CE Mark for fixOflex Endocapsular Device

PR NewswireFebruary 13, 2026February 13, 2026

by PR NewswireFebruary 13, 2026February 13, 2026033

EYE PCR announces that its fixOflex endocapsular device has received CE Mark certification under the European Union Medical Device Regulation (EU MDR 2017/745), enabling commercialization...

Clinical Research, Pharma & Healthcare Financing

EXO 001 Platform Enables In Vivo Multi-Target CAR-T Therapy

PR NewswireFebruary 13, 2026February 13, 2026

by PR NewswireFebruary 13, 2026February 13, 2026036

Jointly developed by China Medical University Hospital and Ever Supreme Bio Technology, the platform demonstrates compelling preclinical tumor clearance across multiple models Cancer has long...

Healthcare Quality, Patient Safety & Policy

Health Systems Launch AI Care Standard for Patient Safety

PR NewswireFebruary 13, 2026February 13, 2026

by PR NewswireFebruary 13, 2026February 13, 2026053

Groundbreaking initiative establishes a standard for responsible patient-facing AI A coalition of the nation’s most respected health systems, patient-safety leaders, and clinical and technology innovators...

Clinical Research, Pharma & Healthcare Financing

Agilent Gets FDA Approval for PD-L1 Test in Ovarian Cancer

Business WireFebruary 12, 2026February 13, 2026

by Business WireFebruary 12, 2026February 13, 2026030

Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA® (pembrolizumab)1, 2 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration...

Healthcare Infrastructure, Operations & Supply Chain

WHOOP Launches Advanced Labs in UAE with Unilabs Partnership

Business WireFebruary 12, 2026February 13, 2026

by Business WireFebruary 12, 2026February 13, 2026030

Unilabs will now offer the WHOOP Advanced Labs’ signature 65-biomarker panel throughout the UAE WHOOP, the human performance company, today announced a partnership with Unilabs,...

Clinical Research, Pharma & Healthcare Financing

ICON Updates Timing of Q4 & Full Year 2025 Earnings Report

Business WireFebruary 12, 2026February 13, 2026

by Business WireFebruary 12, 2026February 13, 2026023

Investigation’s preliminary indications are that 2023 and 2024 revenue may have been overstated by less than 2% for each fiscal year ICON plc, (NASDAQ: ICLR)...

Digital Health, Technology & Innovation

Portal Expands Powered by Portal Model for Scientific Innovators

Business WireFebruary 12, 2026February 13, 2026

by Business WireFebruary 12, 2026February 13, 2026027

The initiative expands the Powered by Portal platform with the opening of Ocean State Labs, while introducing access to the Stargaze Network Terminal as a...

Healthcare Infrastructure, Operations & Supply Chain

PharmaResearch Signs Exclusive Rejuran Supply Deal in Brazil

PR NewswireFebruary 11, 2026February 12, 2026

by PR NewswireFebruary 11, 2026February 12, 2026020

PharmaResearch Co., Ltd. (CEO Jihoon Sohn), a leading regenerative medicine company, announced that it has entered into an exclusive supply agreement for Rejuran with DermaDream,...

Workforce Development & Leadership

Andy Garcia Show Features Aesthetic Center on Ethics and Innovation

PR NewswireFebruary 11, 2026February 12, 2026

by PR NewswireFebruary 11, 2026February 12, 2026025

The new Public Television segment examines patient-centered care, surgical discipline, and ethical considerations within the modern field of aesthetic medicine. Public Television audiences will soon...

Healthcare Quality, Patient Safety & Policy

AmacaThera Named Emerging Company of the Year by Life Sciences ON

PR NewswireFebruary 11, 2026February 12, 2026

by PR NewswireFebruary 11, 2026February 12, 2026026

AmacaThera, a leading developer of next-generation hydrogel-based drug delivery solutions that enable precise, tunable, and sustained release to improve a wide range of active therapeutics, today...

Healthcare and Pharmaceutical The Inner Circle

Indigenous Participation in Climate and Health Governance

BI JournalFebruary 11, 2026February 11, 2026

by BI JournalFebruary 11, 2026February 11, 2026063

Explore how Indigenous participation in climate and health governance drives sustainable, culturally informed policies and more resilient outcomes. Indigenous Peoples were direct participants in climate...

Digital Health, Technology & Innovation

ArisGlobal Unveils XDI NavaX Data Intelligence and New Agents

PR NewswireFebruary 11, 2026February 12, 2026

by PR NewswireFebruary 11, 2026February 12, 2026036

ArisGlobal, an AI-first technology company at the forefront of Life Sciences and creator of LifeSphere®, has announced five significant new product offerings to drive cross-functional operationalization of...

Clinical Research, Pharma & Healthcare Financing

Akeso’s IL-4Rα/ST2 Antibody Cleared for Seven Phase II Trials

PR NewswireFebruary 11, 2026February 12, 2026

by PR NewswireFebruary 11, 2026February 12, 2026037

Akeso, Inc. (9926.HK) is pleased to announce that the National Medical Products Administration has approved the initiation of Phase II clinical trials for AK139, a...

Category : Healthcare and Pharmaceutical

EU Approves Amgen’s UPLIZNA for Generalized Myasthenia

HanchorBio Gets FDA Orphan Drug Status for HCB101

EYE PCR Gets CE Mark for fixOflex Endocapsular Device

EXO 001 Platform Enables In Vivo Multi-Target CAR-T Therapy

Health Systems Launch AI Care Standard for Patient Safety

Agilent Gets FDA Approval for PD-L1 Test in Ovarian Cancer

WHOOP Launches Advanced Labs in UAE with Unilabs Partnership

ICON Updates Timing of Q4 & Full Year 2025 Earnings Report

Portal Expands Powered by Portal Model for Scientific Innovators

PharmaResearch Signs Exclusive Rejuran Supply Deal in Brazil

Andy Garcia Show Features Aesthetic Center on Ethics and Innovation

AmacaThera Named Emerging Company of the Year by Life Sciences ON

Indigenous Participation in Climate and Health Governance

ArisGlobal Unveils XDI NavaX Data Intelligence and New Agents

Akeso’s IL-4Rα/ST2 Antibody Cleared for Seven Phase II Trials

K12 Coalition™ Launches Teaching Channel+ for District PD

NAMI Announces Appointment of Nathan Paul Romano to...

Incident IQ Launches AI to Boost K–12 IT...

NoMIS Power Expands Medium-Voltage SiC MOSFETs to 3.3...

Fund Proxy Reforms Would Save Funds and Investors...

Quick Links

Stay up to date